🔎 Trials Near Me

Почетна › Ulcerativni kolitis › Ilinois › Chicago

Kliničke studije za Ulcerativni kolitis u gradu Chicago, IL

13 studija za Ulcerativni kolitis traži učesnike na lokacijama u gradu Chicago i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Тражи се учесникФаза 2
  • Northwestern University, Chicago
  • Rush University Medical Center, Chicago
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07415044

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Тражи се учесникФаза 2
  • Rush University Medical Center, Chicago
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483073

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Тражи се учесникФаза 3
  • Rush University Medical Center, Chicago
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Тражи се учесникФаза 2
  • Northwestern University, Chicago
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07186101

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Тражи се учесникФаза 2
  • University of Chicago Medical Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06979336

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Тражи се учесникФаза 2
  • University of Chicago Medical Center, Chicago
Узраст од 12 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT05287126

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Тражи се учесникФаза 2
  • Site 038, Chicago
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07012395

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Тражи се учесникФаза 3
  • University of Chicago Medical Center /ID# 271588, Chicago
Узраст од 2 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT07071519

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Тражи се учесникОпсервациона студија
  • Feinberg School of Medicine Northwestern University, Chicago
  • Rush University Medical Center, Chicago
Узраст од 18 до 64 · Оба пола · Ажурирано 26. 10. 2026. · NCT06398626

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Тражи се учесникФаза 3
  • Rush University Medical Center - Site Number: 8400015, Chicago
Узраст од 16 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07184996

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

Тражи се учесник
  • University of Chicago, Chicago
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 10. 2026. · NCT06693310

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Тражи се учесник
  • University of Chicago Medicine, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT05230173

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Тражи се учесникФаза 2
  • Northwestern University, Chicago
Узраст од 18 до 85 · Оба пола · Ажурирано 22. 5. 2026. · NCT07427017

Studije za Ulcerativni kolitis u drugim gradovima

Ostale studije u gradu Chicago

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.